Comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 vs 16p11 2p12 2 Microduplication Syndrome C4518821
Clinical comparison between 3 Beta Hydroxysteroid Dehydrogenase Deficiency and 16p11 2p12 2 Microduplication Syndrome for differential diagnosis and treatment planning.
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
A rare genetic disorder affecting adrenal hormone production. It can cause ambiguous genitalia, salt-wasting crises, and hormonal imbalances. Treatment requires hormone replacement therapy and careful monitoring.
16p11 2p12 2 Microduplication Syndrome C4518821
A rare genetic condition involving extra genetic material on chromosome 16. It may affect development and be associated with developmental delays, learning difficulties, and distinctive features in some individuals. Management involves supportive therapies.
6 comparison axes
Onset
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
0-null
16p11 2p12 2 Microduplication Syndrome C4518821
0-null
Onset patterns differ
Severity
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
severe
16p11 2p12 2 Microduplication Syndrome C4518821
moderate
Different severity levels
Chronic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Chronic
16p11 2p12 2 Microduplication Syndrome C4518821
Chronic
Differing course
Communicable
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
No
16p11 2p12 2 Microduplication Syndrome C4518821
No
Different transmission
Body System
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
16p11 2p12 2 Microduplication Syndrome C4518821
congenital
Same/different system
Category
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
16p11 2p12 2 Microduplication Syndrome C4518821
genetic
Different category
Bottom line
3-beta-hydroxysteroid-dehydrogenase-deficiency-C0342471 and 16p11-2p12-2-microduplication-syndrome-C4518821 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Discriminating power |
|---|---|---|---|
| Salt-wasting crisis | May occur in infancy with dehydration and electrolyte imbalance. | Not a described feature of this chromosomal condition. | High |
| Genital development | Ambiguous genitalia may occur because of impaired steroid synthesis. | Genital ambiguity is not an established core feature. | High |
| Development and learning | Not the primary described manifestation. | Developmental delay and learning difficulty may occur in some people. | Moderate |
When to favor each condition
Choose 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 when
Infant with suspected adrenal crisis
Hormone-production disorder can cause salt wasting and requires urgent endocrine assessment.
High
Abnormal steroid profile
A pattern suggesting impaired steroid synthesis supports specialist biochemical evaluation.
Moderate
Ambiguous genitalia with endocrine concern
This finding may prompt evaluation for a disorder of sex development.
Moderate
Choose 16p11 2p12 2 Microduplication Syndrome C4518821 when
Developmental delay without endocrine crisis
A chromosomal copy-number condition may be considered among genetic causes.
Moderate
Chromosomal microarray finding
Detection of the relevant duplication supports genetics review and phenotype correlation.
High
Learning difficulty with congenital features
Supportive developmental assessment is appropriate, but the finding alone is not diagnostic.
Low
How key tests differ
| Test | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 16p11 2p12 2 Microduplication Syndrome C4518821 | Interpretation |
|---|---|---|---|
| Steroid hormone profile | May show abnormal adrenal or gonadal steroid patterns. | No characteristic steroid abnormality is established. | Abnormal results suggest an endocrine disorder but require specialist confirmation. |
| Electrolytes during illness | Salt wasting may cause clinically important electrolyte disturbance. | No specific electrolyte pattern is established. | Results distinguish acute endocrine risk, not the chromosomal diagnosis. |
| Chromosomal microarray | Not the primary diagnostic test for this enzyme disorder. | May identify extra material in the relevant chromosome 16 region. | A genomic result needs clinical correlation and genetic counseling. |
Prognosis comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
- Outcome
- Potentially serious but variable; outcomes depend on recognition and endocrine management.
- Factors
- Salt-wasting risk, hormone control, and associated complications.
16p11 2p12 2 Microduplication Syndrome C4518821
- Outcome
- Generally described as moderate, with variable developmental effects.
- Factors
- Extent of developmental needs and associated congenital findings.
Time frame: Both are chronic; exact outcomes are not established here.
Individual genetics, early care, comorbidities, and access to specialist support.
Complications comparison
| Complication | Presentation |
|---|---|
| Acute adrenal insufficiency | A recognized potential complication requiring urgent care. Not established as a feature. Emergency evaluation is needed for suspected adrenal crisis. |
| Developmental impairment | Not described as the main complication. Delays or learning difficulties may affect some individuals. Severity and presence are variable and not predictable from the label alone. |
| Long-term hormone imbalance | May require ongoing hormone replacement and monitoring. No specific endocrine replacement need is established. Treatment decisions belong to the responsible clinicians. |
Patient education highlights
- HighDifferent conditions
These diagnoses involve different genes, tests, and management pathways and should not be inferred from overlapping nonspecific features.
- HighUrgent symptoms
Poor feeding, vomiting, dehydration, or collapse in an infant needs immediate medical assessment.
- MediumSupportive care
Developmental, educational, endocrine, and genetic follow-up should be individualized.